Leora Balsam to Graft Rejection
This is a "connection" page, showing publications Leora Balsam has written about Graft Rejection.
Connection Strength
0.457
-
Balsam LB, Mokhtari GK, Jones S, Peterson S, Hoyt EG, Kofidis T, Tanaka M, Cooke DT, Robbins RC. Early inhibition of caspase-3 activity lessens the development of graft coronary artery disease. J Heart Lung Transplant. 2005 Jul; 24(7):827-32.
Score: 0.222
-
Balsam LB, Robbins RC. Current trends in heart transplantation. Scand J Surg. 2007; 96(2):125-30.
Score: 0.062
-
Tanaka M, Zwierzchoniewska M, Mokhtari GK, Terry RD, Balsam LB, Robbins RC, Fedoseyeva EV. Progression of alloresponse and tissue-specific immunity during graft coronary artery disease. Am J Transplant. 2005 Jun; 5(6):1286-96.
Score: 0.055
-
Tanaka M, Mokhtari GK, Terry RD, Balsam LB, Lee KH, Kofidis T, Tsao PS, Robbins RC. Overexpression of human copper/zinc superoxide dismutase (SOD1) suppresses ischemia-reperfusion injury and subsequent development of graft coronary artery disease in murine cardiac grafts. Circulation. 2004 Sep 14; 110(11 Suppl 1):II200-6.
Score: 0.053
-
Tanaka M, Nakae S, Terry RD, Mokhtari GK, Gunawan F, Balsam LB, Kaneda H, Kofidis T, Tsao PS, Robbins RC. Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection, and graft coronary artery disease. Blood. 2004 Dec 01; 104(12):3789-96.
Score: 0.052
-
Tanaka M, Mokhtari GK, Balsam LB, Cooke DT, Kofidis T, Zwierzchonievska M, Robbins RC. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model. J Heart Lung Transplant. 2005 Apr; 24(4):446-53.
Score: 0.014